Berkshire Hathaway Inc.
BRK-B
$495.52
+1.28%
Berkshire Hathaway Inc. is a diversified holding company with core operations spanning insurance, freight rail transportation, and utilities, alongside a vast portfolio of manufacturing, service, and retailing businesses. It is distinguished as a market leader and a unique conglomerate, renowned for its long-term value investing philosophy, decentralized management structure, and fortress-like balance sheet under the stewardship of Warren Buffett and Charlie Munger. The current investor narrative centers on the company's succession planning and capital allocation strategy, as markets evaluate its ability to deploy its massive cash reserves effectively in a high-interest rate environment and navigate economic cycles through its cyclical industrial and insurance operations.…
BRK-B
Berkshire Hathaway Inc.
$495.52
BRK-B 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Berkshire Hathaway Inc.'s 12-month outlook, with a consensus price target around $644.18 and implied upside of +30.0% versus the current price.
Average Target
$644.18
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$396 - $644
Analyst target range
Analyst coverage for Berkshire Hathaway is notably sparse, with data indicating only one analyst providing formal estimates, which is highly unusual for a company of its size and stature; this results in insufficient data to derive a meaningful consensus recommendation, target price, or implied upside/downside, limiting traditional sentiment analysis. The implication of such minimal coverage is that the stock is largely analyzed and valued by the market itself and through the lens of its annual reports and shareholder letters, rather than by sell-side research; this can lead to periods of price inefficiency and higher volatility driven by macro and fundamental news, as opposed to analyst rating changes, though the consistent 'Buy' rating from the sole covering firm (UBS) over many quarters indicates a stable, long-term bullish view from the limited institutional research that exists.
BRK-B Technical Analysis
The stock is in a sustained downtrend and consolidation phase, with a 1-year price change of -0.22% as of the latest data, significantly underperforming the S&P 500's 22.86% gain. Currently trading at $489.25, it sits approximately 55% of the way up from its 52-week low of $455.19 towards its high of $516.85, indicating it is in the lower-middle portion of its annual range, which suggests a lack of bullish momentum and potential value-oriented interest. Recent short-term momentum shows modest signs of stabilization, with a 1-month price increase of 0.77% and a 3-month decline of -0.16%, diverging from the more negative 6-month trend of -2.06%; this divergence could signal a tentative pause in the downtrend or a base-building phase, though the persistent negative relative strength versus the market (e.g., -23.08% over 1-year) underscores its weakness. Key technical support is clearly defined at the 52-week low of $455.19, while resistance lies near the 52-week high of $516.85; a decisive break above resistance would signal a potential trend reversal, while a breakdown below support could trigger further selling. The stock's beta of 0.617 indicates it is approximately 38% less volatile than the broader market, which is characteristic of its defensive, conglomerate nature and matters for investors seeking lower-risk equity exposure.
Beta
0.62
0.62x market volatility
Max Drawdown
-14.9%
Largest decline past year
52-Week Range
$455-$517
Price range past year
Annual Return
+1.6%
Cumulative gain past year
| Period | BRK-B Return | S&P 500 |
|---|---|---|
| 1m | +2.7% | +2.1% |
| 3m | +0.6% | +12.5% |
| 6m | -1.7% | +12.4% |
| 1y | +1.6% | +26.4% |
| ytd | -0.3% | +10.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BRK-B Fundamental Analysis
Revenue growth has been inconsistent and recently negative, with Q4 2025 revenue of $94.23 billion representing a -7.13% year-over-year decline; this follows a volatile pattern across recent quarters, including Q3 2025 revenue of $94.97 billion and Q2 2025 revenue of $98.88 billion, indicating top-line pressure likely from its insurance underwriting and cyclical industrial segments. The company remains highly profitable, with Q4 2025 net income of $19.20 billion and a net margin of 20.37%, though profitability is volatile quarter-to-quarter (e.g., Q3 2025 net income was $30.80 billion); the gross margin for Q4 2025 was 23.01%, which has compressed from higher levels seen in prior quarters like Q2 2025's 44.56%, reflecting mix shifts and potential cost pressures in its operating businesses. Berkshire's balance sheet and cash flow are exceptionally strong, featuring a robust current ratio of 6.75, a very low debt-to-equity ratio of 0.19, and substantial annual free cash flow of $25.04 billion (TTM); this immense financial strength, coupled with a Return on Equity (ROE) of 9.33%, demonstrates its ability to fund growth and acquisitions internally without reliance on excessive leverage, providing a significant margin of safety.
Quarterly Revenue
$94.2B
2025-12
Revenue YoY Growth
-0.07%
YoY Comparison
Gross Margin
+0.23%
Latest Quarter
Free Cash Flow
$25.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BRK-B Overvalued?
Given its substantial positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 16.19x, while the forward PE is 22.78x; the higher forward multiple suggests the market anticipates a near-term earnings decline, which aligns with the recent quarterly net income volatility and the estimated EPS of $21.72 for the coming period. Compared to the broader market and its own sector, Berkshire's trailing PE of 16.19x is difficult to benchmark directly against a pure industry average due to its conglomerate structure, but it trades at a significant discount to the high-growth tech sector, while its Price-to-Sales (PS) ratio of 2.92x and Price-to-Book (PB) ratio of 1.51x suggest a valuation grounded in asset and earnings power rather than speculative growth. Historically, the stock's current trailing PE of 16.19x sits below its own multi-year range observed in the historical data, which has seen peaks above 60x during low-earnings quarters and troughs near 5x; this positioning in the lower half of its historical band suggests the market is not pricing in overly optimistic expectations, potentially offering a reasonable entry point for a quality compounder.
PE
16.2x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -52x~62x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.2x
Enterprise Value Multiple
